Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5065-5077

  Chen, Hsin Yu ^a   Wang, Li Tzu ^a,c   Wang, Fu Hui ^a   Fang, Li Wen ^d   Lai, Hsiu Yu ^e   Chen, Hsuan Hsu ^a   Lu, Jean ^f   Hung, Ming Shiu ^a   Cheng, Yao ^a   Chen, Mei Yu ^a   Liu, Shih Jen ^a,b   Chong, Pele ^a,b   Lee, Oscar Kuang Sheng ^d,e,g   Hsu, Shu Ching ^a,c,h  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d IShou University   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT REJECTION; GROWTH REGULATED ONCOGENE; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTIGENS, CD14; ARGINASE; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOKINES, CXC; DENDRITIC CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MONOCYTES; MYELOID CELLS; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877836310     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202775     Document Type: Article

References (50)

1. Friedenstein, A. J., K. V. Petrakova, A. I. Kurolesova, and G. P. Frolova. 1968. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6: 230-247.
2. Bernardo, M. E., F. Locatelli, and W. E. Fibbe. 2009. Mesenchymal stromal cells. Ann. N. Y. Acad. Sci. 1176: 101-117.
3. Aquino, J. B., M. F. Bolontrade, M. G. García, O. L. Podhajcer, and G. Mazzolini. 2010. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther. 17: 692-708.
4. Vanleene, M., Z. Saldanha, K. L. Cloyd, G. Jell, G. Bou-Gharios, J. H. Bassett, G. R. Williams, N. M. Fisk, M. L. Oyen, M. M. Stevens, et al. 2011. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117: 1053-1060.
5. Popp, F. C., P. Renner, E. Eggenhofer, P. Slowik, E. K. Geissler, P. Piso, H. J. Schlitt, and M. H. Dahlke. 2009. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl. 15: 1192-1198.
6. Sato, K., K. Ozaki, M. Mori, K. Muroi, and K. Ozawa. 2010. Mesenchymal stromal cells for graft-versus-host disease: basic aspects and clinical outcomes. J. Clin. Exp. Hematop. 50: 79-89.
7. Nauta, A. J., and W. E. Fibbe. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506. (Pubitemid 350159613)
8. Muller, I., S. Lymperi, and F. Dazzi. 2008. Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr. Opin. Organ Transplant. 13: 639-644.
9. Yagi, H., A. Soto-Gutierrez, B. Parekkadan, Y. Kitagawa, R. G. Tompkins, N. Kobayashi, and M. L. Yarmush. 2010. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 19: 667-679.
10. Mougiakakos, D., R. Jitschin, C. C. Johansson, R. Okita, R. Kiessling, and K. Le Blanc. 2011. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood. 117: 4826-4835.
11. Prigione, I., F. Benvenuto, P. Bocca, L. Battistini, A. Uccelli, and V. Pistoia. 2009. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 27: 693-702.
12. Jarvinen, L., L. Badri, S. Wettlaufer, T. Ohtsuka, T. J. Standiford, G. B. Toews, D. J. Pinsky, M. Peters-Golden, and V. N. Lama. 2008. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J. Immunol. 181: 4389-4396.
13. Kim, J., and P. Hematti. 2009. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp. Hematol. 37: 1445-1453.
14. Rasmusson, I., K. Le Blanc, B. Sundberg, and O. Ringdén. 2007. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol. 65: 336-343. (Pubitemid 46481102)
15. + T cells. Immunobiology. 218: 90-95.
16. Aggarwal, S., and M. F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
17. Spaggiari, G. M., H. Abdelrazik, F. Becchetti, and L. Moretta. 2009. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583.
18. Richmond, A., and H. G. Thomas. 1988. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J. Cell. Biochem. 36: 185-198. (Pubitemid 18034925)
19. Loukinova, E., G. Dong, I. Enamorado-Ayalya, G. R. Thomas, Z. Chen, H. Schreiber, and C. Van Waes. 2000. Growth regulated oncogene-Alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 19: 3477-3486. (Pubitemid 30487445)
20. Keeley, E. C., B. Mehrad, and R. M. Strieter. 2010. CXC chemokines in cancer angiogenesis and metastases. Adv. Cancer Res. 106: 91-111.
21. Smith, D. F., E. Galkina, K. Ley, and Y. Huo. 2005. GRO family chemokines are specialized for monocyte arrest from flow. Am. J. Physiol. Heart Circ. Physiol. 289: H1976-H1984. (Pubitemid 41507347)
22. Rainard, P., C. Riollet, P. Berthon, P. Cunha, A. Fromageau, C. Rossignol, and F. B. Gilbert. 2008. The chemokine CXCL3 is responsible for the constitutive chemotactic activity of bovine milk for neutrophils. Mol. Immunol. 45: 4020-4027.
23. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
24. Lee, O. K., T. K. Kuo, W. M. Chen, K. D. Lee, S. L. Hsieh, and T. H. Chen. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675. (Pubitemid 38268958)
25. Mahanonda, R., N. Sa-Ard-Iam, P. Montreekachon, A. Pimkhaokham, K. Yongvanichit, M. M. Fukuda, and S. Pichyangkul. 2007. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J. Immunol. 178: 1151-1157. (Pubitemid 46095188)
26. Song, Y. C., A. H. Chou, A. Homhuan, M. H. Huang, S. K. Chiang, K. Y. Shen, P. W. Chuang, C. H. Leng, M. H. Tao, P. Chong, and S. J. Liu. 2011. Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosisindependent pathway in vivo. J. Leukoc. Biol. 90: 323-332.
27. Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
28. Condamine, T., and D. I. Gabrilovich. 2011. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32: 19-25.
29. Shi, Y., G. Hu, J. Su, W. Li, Q. Chen, P. Shou, C. Xu, X. Chen, Y. Huang, Z. Zhu, et al. 2010. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 20: 510-518.
30. Kronsteiner, B., A. Peterbauer-Scherb, R. Grillari-Voglauer, H. Redl, C. Gabriel, M. van Griensven, and S. Wolbank. 2011. Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell. Immunol. 267: 30-38.
31. Meisel, R., S. Brockers, K. Heseler, O. Degistirici, H. Bulle, C. Woite, S. Stuhlsatz, W. Schwippert, M. Jager, R. Sorg, et al. 2011. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25: 648-654.
32. Ghannam, S., C. Bouffi, F. Djouad, C. Jorgensen, and D. Noe?l. 2010. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1: 2.
33. Liu, C. H., and S. M. Hwang. 2005. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32: 270-279.
34. Volarevic, V., A. Al-Qahtani, N. Arsenijevic, S. Pajovic, and M. L. Lukic. 2010. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 43: 255-263.
35. +-derived and monocyte-derived dendritic cells. J. Immunol. 177: 2080-2087. (Pubitemid 44200965)
36. Jiang, X. X., Y. Zhang, B. Liu, S. X. Zhang, Y. Wu, X. D. Yu, and N. Mao. 2005. Human mesenchymal stem cells inhibit differentiation and function of monocytederived dendritic cells. Blood 105: 4120-4126. (Pubitemid 40656164)
37. Chiesa, S., S. Morbelli, S. Morando, M. Massollo, C. Marini, A. Bertoni, F. Frassoni, S. T. Bartolomé, G. Sambuceti, E. Traggiai, and A. Uccelli. 2011. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc. Natl. Acad. Sci. USA 108: 17384-17389.
38. Aldinucci, A., L. Rizzetto, L. Pieri, D. Nosi, P. Romagnoli, T. Biagioli, B. Mazzanti, R. Saccardi, L. Beltrame, L. Massacesi, et al. 2010. Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. J. Immunol. 185: 5102-5110.
39. Reiland, J., L. T. Furcht, and J. B. McCarthy. 1999. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 41: 78-88. (Pubitemid 29446962)
40. Vandercappellen, J., J. Van Damme, and S. Struyf. 2008. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267: 226-244.
41. + CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Cytokine 56: 616-620.
42. Doll, D., L. Keller, M. Maak, A. L. Boulesteix, J. R. Siewert, B. Holzmann, and K. P. Janssen. 2010. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int. J. Colorectal Dis. 25: 573-581.
43. Singh, S., K. C. Nannuru, A. Sadanandam, M. L. Varney, and R. K. Singh. 2009. CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br. J. Cancer 100: 1638-1646.
44. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
45. Haile, L. A., R. von Wasielewski, J. Gamrekelashvili, C. Kruger, O. Bachmann, A. M. Westendorf, J. Buer, R. Liblau, M. P. Manns, F. Korangy, et al. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881, 881.e1-5.
46. Montero, A. J., C. M. Diaz-Montero, C. E. Kyriakopoulos, V. Bronte, and S. Mandruzzato. 2012. Myeloid-derived suppressor cells in cancer patients: a clinical perspective. J. Immunother. 35: 107-115.
47. +) T cells. Gastroenterology 135: 234-243. (Pubitemid 351899008)
48. Salem, H. K., and C. Thiemermann. 2010. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28: 585-596.
49. Yin, B., G. Ma, C. Y. Yen, Z. Zhou, G. X. Wang, C. M. Divino, S. Casares, S. H. Chen, W. C. Yang, and P. Y. Pan. 2010. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J. Immunol. 185: 5828-5834.
50. Ioannou, M., T. Alissafi, I. Lazaridis, G. Deraos, J. Matsoukas, A. Gravanis, V. Mastorodemos, A. Plaitakis, A. Sharpe, D. Boumpas, and P. Verginis. 2012. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 188: 1136-1146.